التفاصيل البيبلوغرافية
| العنوان: |
547 CERPASS: A randomized, controlled, open-label, phase 2 study of cemiplimab ± RP1 in patients with advanced cutaneous squamous cell carcinoma |
| المؤلفون: |
Andrew Haydon, Celeste Lebbe, Jose Lutzky, Gregory Daniels, Ragini Kudchadkar, Ann Silk, Nikhil Khushalani, Frances Collichio, Jean-Jaques Grob, Samantha Bowyer, Praveen Bommareddy, Andrew Hill, Danny Rischin, Daniel Brungs, Michael Migden, Matthew Fury, Jenny Lee, Muhammad Alamgeer, Dimitrios Colevas, Wanxing Chai-Ho, Piyush Sheladia, Shui He, Claudia Andreu-Vieyra |
| المصدر: |
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021) |
| بيانات النشر: |
BMJ Publishing Group, 2021. |
| سنة النشر: |
2021 |
| المجموعة: |
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
| مصطلحات موضوعية: |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
| نوع الوثيقة: |
article |
| وصف الملف: |
electronic resource |
| اللغة: |
English |
| تدمد: |
2051-1426 |
| العلاقة: |
https://doaj.org/toc/2051-1426Test |
| DOI: |
10.1136/jitc-2021-SITC2021.547 |
| الوصول الحر: |
https://doaj.org/article/167192fa3f6d4054be25ce205537925eTest |
| رقم الانضمام: |
edsdoj.167192fa3f6d4054be25ce205537925e |
| قاعدة البيانات: |
Directory of Open Access Journals |
Full Text Finder